What is the current annual EBIT of ISRG?

As of today, ISRG annual EBIT is $2.95B

What is 1-year change in ISRG annual EBIT?

ISRG annual EBIT is up +25.40% year-over-year

What is 3-year change in ISRG annual EBIT?

ISRG annual EBIT is up +86.77% over the past 3 years

How far is ISRG annual EBIT from its all-time high?

ISRG annual EBIT is currently at its all-time high

How does ISRG annual EBIT rank versus sector peers?

ISRG annual EBIT is higher than 97.37% of companies in Healthcare sector

When is ISRG next annual earnings release?

As of today, the next annual earnings release for ISRG has not been scheduled

What is the current quarterly EBIT of ISRG?

As of today, ISRG quarterly EBIT is $864.30M

What is ISRG quarterly EBIT most recent change?

ISRG quarterly EBIT was up +13.77% on December 31, 2025

What is 1-year change in ISRG quarterly EBIT?

ISRG quarterly EBIT is up +17.61% year-over-year

How far is ISRG quarterly EBIT from its all-time high?

ISRG quarterly EBIT is currently at its all-time high

How does ISRG quarterly EBIT rank versus sector peers?

ISRG quarterly EBIT is higher than 97.76% of companies in Healthcare sector

When is ISRG next earnings release?

The next earnings release for ISRG is on April 21, 2026

What is the current TTM EBIT of ISRG?

As of today, ISRG TTM EBIT is $2.95B

What is ISRG TTM EBIT most recent change?

ISRG TTM EBIT was up +4.60% on December 31, 2025

What is 1-year change in ISRG TTM EBIT?

ISRG TTM EBIT is up +25.40% year-over-year

How far is ISRG TTM EBIT from its all-time high?

ISRG TTM EBIT is currently at its all-time high

How does ISRG TTM EBIT rank versus sector peers?

ISRG TTM EBIT is higher than 97.14% of companies in Healthcare sector

When is ISRG next earnings release?

The next earnings release for ISRG is on April 21, 2026

ISRG EBIT History & Chart Since 1998

Annual EBIT

$2.95B$596.60M+25.40%

December 31, 2025

Summary

Current Value: As of today, ISRG annual EBIT is $2.95B, up +25.40% on December 31, 2025
Historical Performance: ISRG annual EBIT is up +86.77% over the past 3 years, and up +180.90% over the past 5 years
All-Time High Comparison: ISRG annual EBIT is currently at its all-time high
3-Year Low Comparison: ISRG annual EBIT is +86.77% above its 3-year low of $1.58B reached on an earlier date
Sector Comparison: ISRG annual EBIT is higher than 97.37% of companies in Healthcare sector

EBIT Chart

Add series to chart

Add series to chart1/6

Company, ETF, index, screener or watchlist

Series

Performance

ISRG Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual EBIT	Dec 31, 25	$2.95B	+25.4%	+86.8%	+180.9%	+430.5%
Quarterly EBIT	Dec 31, 25	$864.30M	+17.6%	+132.0%	+107.9%	+462.3%
TTM EBIT	Dec 31, 25	$2.95B	+25.4%	+86.8%	+180.6%	+432.4%
Price	Jan 30, 26	$505.22	-12.9%	+108.6%	+102.7%	+1286.6%
PE Ratio	Jan 30, 26	64.11	-29.1%	-3.4%	-24.5%	+85.1%
Annual Revenue	Dec 31, 25	$10.06B	+20.5%	+61.8%	+130.9%	+612.3%
Annual EPS	Dec 31, 25	$7.87	+22.7%	+115.5%	+167.8%	+648.0%
Annual EBITDA	Dec 31, 25	-	–	–	–	–
Annual Net Income	Dec 31, 25	$2.88B	+23.1%	+114.0%	+169.7%	+653.4%

EBIT Highs

ISRG Annual EBIT Highs Comparison
Period	High	Date	Current
3Y	$2.95B	Dec 31, 25	at high
5Y	$2.95B	Dec 31, 25	at high
All	$2.95B	Dec 31, 25	at high

EBIT Lows

ISRG Annual EBIT Lows Comparison
Period	Low	Date	Current
3Y	$1.58B	N/A	+86.8%
5Y	$1.05B	N/A	+180.9%
All	-$30.77M	Dec 31, 98	+9671.7%

EBIT History

Year	Value	Change
2025	$2.95B	+25.4%
2024	$2.35B	+32.9%
2023	$1.77B	+12.0%
2022	$1.58B	-13.4%
2021	$1.82B	+73.7%
2020	$1.05B	-23.7%
2019	$1.38B	+10.5%
2018	$1.24B	+14.4%
2017	$1.09B	+13.8%
2016	$956.40M	+28.2%
2015	$746.00M	+20.4%
2014	$619.70M	-27.2%
2013	$850.70M	-3.0%
2012	$877.00M	+26.1%

Year	Value	Change
2011	$695.50M	+25.3%
2010	$555.20M	+47.5%
2009	$376.29M	+21.1%
2008	$310.84M	+49.8%
2007	$207.56M	+93.3%
2006	$107.36M	+56.1%
2005	$68.77M	+224.6%
2004	$21.18M	+520.4%
2003	-$5.04M	+75.1%
2002	-$20.22M	+0.8%
2001	-$20.38M	+8.5%
2000	-$22.28M	-14.0%
1999	-$19.55M	+36.5%
1998	-$30.77M	-

FAQ

What is the current annual EBIT of ISRG?
As of today, ISRG annual EBIT is $2.95B
What is 1-year change in ISRG annual EBIT?
ISRG annual EBIT is up +25.40% year-over-year
What is 3-year change in ISRG annual EBIT?
ISRG annual EBIT is up +86.77% over the past 3 years
How far is ISRG annual EBIT from its all-time high?
ISRG annual EBIT is currently at its all-time high
How does ISRG annual EBIT rank versus sector peers?
ISRG annual EBIT is higher than 97.37% of companies in Healthcare sector
When is ISRG next annual earnings release?
As of today, the next annual earnings release for ISRG has not been scheduled

Quarterly EBIT

$864.30M$104.60M+13.77%

December 31, 2025

Summary

Current Value: As of today, ISRG quarterly EBIT is $864.30M, up +13.77% on December 31, 2025
Historical Performance: ISRG quarterly EBIT is up +17.61% year-over-year, and up +132.03% over the past 3 years
All-Time High Comparison: ISRG quarterly EBIT is currently at its all-time high
3-Year Low Comparison: ISRG quarterly EBIT is +132.03% above its 3-year low of $372.50M reached on an earlier date
Sector Comparison: ISRG quarterly EBIT is higher than 97.76% of companies in Healthcare sector

Performance

ISRG Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly EBIT	Dec 31, 25	$864.30M	+13.8%	+17.6%	+132.0%	+107.9%
Annual EBIT	Dec 31, 25	$2.95B	–	+25.4%	+86.8%	+180.9%
TTM EBIT	Dec 31, 25	$2.95B	+4.6%	+25.4%	+86.8%	+180.6%
Price	Jan 30, 26	$505.22	-4.7%	-12.9%	+108.6%	+102.7%
PE Ratio	Jan 30, 26	64.11	-8.6%	-29.1%	-3.4%	-24.5%
Quarterly Revenue	Dec 31, 25	$2.87B	+14.4%	+18.8%	+73.2%	+115.7%
Quarterly EPS	Dec 31, 25	$2.21	+13.5%	+17.3%	+142.8%	+119.9%
Quarterly EBITDA	Dec 31, 25	-	–	–	–	–
Quarterly Net Income	Dec 31, 25	$799.50M	+12.7%	+16.2%	+137.4%	+119.9%

Quarterly EBIT Highs

ISRG Quarterly EBIT Highs Comparison
Period	High	Date	Current
1Y	$864.30M	Dec 31, 25	at high
3Y	$864.30M	Dec 31, 25	at high
5Y	$864.30M	Dec 31, 25	at high
All	$864.30M	Dec 31, 25	at high

Quarterly EBIT Lows

ISRG Quarterly EBIT Lows Comparison
Period	Low	Date	Current
1Y	$578.10M	Mar 31, 25	+49.5%
3Y	$372.50M	N/A	+132.0%
5Y	$372.50M	Dec 31, 22	+132.0%
All	-$6.84M	Sep 30, 02	>+9999.0%

Quarterly EBIT History

Month	Value	Change
Dec 2025	$864.30M	+13.8%
Sep 2025	$759.70M	+2.2%
Jun 2025	$743.40M	+28.6%
Mar 2025	$578.10M	-21.3%
Dec 2024	$734.90M	+27.3%
Sep 2024	$577.30M	+1.8%
Jun 2024	$567.30M	+20.9%
Mar 2024	$469.40M	+4.3%
Dec 2023	$450.20M	-3.3%
Sep 2023	$465.80M	+0.6%
Jun 2023	$463.20M	+19.5%
Mar 2023	$387.60M	+4.1%
Dec 2022	$372.50M	-6.6%
Sep 2022	$398.90M	+0.3%
Jun 2022	$397.60M	-2.6%
Mar 2022	$408.10M	-9.4%
Dec 2021	$450.40M	+1.8%
Sep 2021	$442.60M	-13.4%
Jun 2021	$511.20M	+22.6%
Mar 2021	$416.80M	+0.2%
Dec 2020	$415.80M	+53.8%
Sep 2020	$270.40M	+235.5%
Jun 2020	$80.60M	-71.5%
Mar 2020	$283.00M	-28.8%
Dec 2019	$397.60M	+8.7%
Sep 2019	$365.70M	+1.9%
Jun 2019	$359.00M	+42.3%
Mar 2019	$252.20M	-23.9%
Dec 2018	$331.30M	+6.4%
Sep 2018	$311.50M	-2.6%
Jun 2018	$319.90M	+11.7%
Mar 2018	$286.40M	-14.6%
Dec 2017	$335.30M	+15.4%
Sep 2017	$290.60M	+8.1%
Jun 2017	$268.90M	+22.0%
Mar 2017	$220.40M	-17.7%
Dec 2016	$267.70M	+3.8%
Sep 2016	$257.80M	+1.1%
Jun 2016	$255.00M	+40.0%
Mar 2016	$182.20M	-25.3%
Dec 2015	$243.80M	+28.8%
Sep 2015	$189.30M	+4.9%
Jun 2015	$180.40M	+31.1%
Mar 2015	$137.60M	-28.1%
Dec 2014	$191.50M	+20.4%
Sep 2014	$159.10M	+4.3%
Jun 2014	$152.60M	+23.1%
Mar 2014	$124.00M	-40.6%
Dec 2013	$208.60M	+19.7%
Sep 2013	$174.20M	-20.3%
Jun 2013	$218.50M	-13.0%
Mar 2013	$251.20M	+1.2%

Month	Value	Change
Dec 2012	$248.10M	+17.4%
Sep 2012	$211.40M	-6.2%
Jun 2012	$225.30M	+16.6%
Mar 2012	$193.30M	-3.1%
Dec 2011	$199.50M	+11.5%
Sep 2011	$178.90M	+6.4%
Jun 2011	$168.10M	+13.4%
Mar 2011	$148.30M	-3.5%
Dec 2010	$153.70M	+16.4%
Sep 2010	$132.10M	-4.1%
Jun 2010	$137.80M	+6.2%
Mar 2010	$129.70M	+1.0%
Dec 2009	$128.38M	+22.9%
Sep 2009	$104.49M	+5.0%
Jun 2009	$99.54M	+121.1%
Mar 2009	$45.03M	-45.6%
Dec 2008	$82.74M	-2.7%
Sep 2008	$85.03M	+8.7%
Jun 2008	$78.20M	+20.5%
Mar 2008	$64.87M	-11.7%
Dec 2007	$73.45M	+35.8%
Sep 2007	$54.08M	+19.1%
Jun 2007	$45.42M	+31.3%
Mar 2007	$34.61M	-2.4%
Dec 2006	$35.45M	+38.1%
Sep 2006	$25.68M	+4.8%
Jun 2006	$24.51M	+12.8%
Mar 2006	$21.73M	-7.6%
Dec 2005	$23.51M	+11.9%
Sep 2005	$21.01M	+37.0%
Jun 2005	$15.34M	+72.1%
Mar 2005	$8.91M	-18.6%
Dec 2004	$10.95M	+99.5%
Sep 2004	$5.49M	+22.8%
Jun 2004	$4.47M	+1,478.4%
Mar 2004	$283.00K	+105.6%
Dec 2003	-$5.01M	-371.6%
Sep 2003	-$1.06M	-300.2%
Jun 2003	$531.00K	+116.9%
Mar 2003	-$3.14M	-4.7%
Dec 2002	-$3.00M	+56.2%
Sep 2002	-$6.84M	-60.3%
Jun 2002	-$4.27M	+30.2%
Mar 2002	-$6.12M	-20.9%
Dec 2001	-$5.06M	+13.3%
Sep 2001	-$5.83M	-18.1%
Jun 2001	-$4.94M	-8.6%
Mar 2001	-$4.55M	+28.0%
Dec 2000	-$6.32M	-16.7%
Sep 2000	-$5.42M	-4.7%
Jun 2000	-$5.17M	+3.6%
Mar 2000	-$5.37M	-

FAQ

What is the current quarterly EBIT of ISRG?
As of today, ISRG quarterly EBIT is $864.30M
What is ISRG quarterly EBIT most recent change?
ISRG quarterly EBIT was up +13.77% on December 31, 2025
What is 1-year change in ISRG quarterly EBIT?
ISRG quarterly EBIT is up +17.61% year-over-year
How far is ISRG quarterly EBIT from its all-time high?
ISRG quarterly EBIT is currently at its all-time high
How does ISRG quarterly EBIT rank versus sector peers?
ISRG quarterly EBIT is higher than 97.76% of companies in Healthcare sector
When is ISRG next earnings release?
The next earnings release for ISRG is on April 21, 2026

TTM EBIT

$2.95B$129.40M+4.60%

December 31, 2025

Summary

Current Value: As of today, ISRG TTM EBIT is $2.95B, up +4.60% on December 31, 2025
Historical Performance: ISRG TTM EBIT is up +25.40% year-over-year, and up +86.77% over the past 3 years
All-Time High Comparison: ISRG TTM EBIT is currently at its all-time high
3-Year Low Comparison: ISRG TTM EBIT is +89.23% above its 3-year low of $1.56B reached on March 31, 2023
Sector Comparison: ISRG TTM EBIT is higher than 97.14% of companies in Healthcare sector

Performance

ISRG Performance
Metric	Date	Value	3M	1Y	3Y	5Y
TTM EBIT	Dec 31, 25	$2.95B	+4.6%	+25.4%	+86.8%	+180.6%
Annual EBIT	Dec 31, 25	$2.95B	–	+25.4%	+86.8%	+180.9%
Quarterly EBIT	Dec 31, 25	$864.30M	+13.8%	+17.6%	+132.0%	+107.9%
Price	Jan 30, 26	$505.22	-4.7%	-12.9%	+108.6%	+102.7%
PE Ratio	Jan 30, 26	64.11	-8.6%	-29.1%	-3.4%	-24.5%
TTM Revenue	Dec 31, 25	$10.06B	+4.7%	+20.5%	+61.8%	+130.9%
TTM EPS	Dec 31, 25	$7.88	+4.3%	+22.9%	+115.8%	+168.6%
TTM EBITDA	Dec 31, 25	-	–	–	–	–
TTM Net Income	Dec 31, 25	$2.88B	+4.0%	+23.1%	+114.0%	+169.7%

TTM EBIT Highs

ISRG TTM EBIT Highs Comparison
Period	High	Date	Current
1Y	$2.95B	Dec 31, 25	at high
3Y	$2.95B	Dec 31, 25	at high
5Y	$2.95B	Dec 31, 25	at high
All	$2.95B	Dec 31, 25	at high

TTM EBIT Lows

ISRG TTM EBIT Lows Comparison
Period	Low	Date	Current
1Y	$2.35B	N/A	+25.4%
3Y	$1.56B	Mar 31, 23	+89.2%
5Y	$1.05B	N/A	+180.6%
All	-$22.28M	Sep 30, 02	>+9999.0%

TTM EBIT History

Month	Value	Change
Dec 2025	$2.95B	+4.6%
Sep 2025	$2.82B	+6.9%
Jun 2025	$2.63B	+7.2%
Mar 2025	$2.46B	+4.6%
Dec 2024	$2.35B	+13.8%
Sep 2024	$2.06B	+5.7%
Jun 2024	$1.95B	+5.6%
Mar 2024	$1.85B	+4.6%
Dec 2023	$1.77B	+4.6%
Sep 2023	$1.69B	+4.1%
Jun 2023	$1.62B	+4.2%
Mar 2023	$1.56B	-1.3%
Dec 2022	$1.58B	-4.7%
Sep 2022	$1.66B	-2.6%
Jun 2022	$1.70B	-6.3%
Mar 2022	$1.81B	-0.5%
Dec 2021	$1.82B	+1.9%
Sep 2021	$1.79B	+10.7%
Jun 2021	$1.61B	+36.4%
Mar 2021	$1.18B	+12.7%
Dec 2020	$1.05B	+1.8%
Sep 2020	$1.03B	-8.5%
Jun 2020	$1.13B	-19.8%
Mar 2020	$1.41B	+2.2%
Dec 2019	$1.37B	+5.1%
Sep 2019	$1.31B	+4.3%
Jun 2019	$1.25B	+3.2%
Mar 2019	$1.21B	-2.7%
Dec 2018	$1.25B	-0.3%
Sep 2018	$1.25B	+1.7%
Jun 2018	$1.23B	+4.3%
Mar 2018	$1.18B	+5.9%
Dec 2017	$1.12B	+6.5%
Sep 2017	$1.05B	+3.2%
Jun 2017	$1.01B	+1.4%
Mar 2017	$1.00B	+4.0%
Dec 2016	$962.70M	+2.5%
Sep 2016	$938.80M	+7.9%
Jun 2016	$870.30M	+9.4%
Mar 2016	$795.70M	+5.9%
Dec 2015	$751.10M	+7.5%
Sep 2015	$698.80M	+4.5%
Jun 2015	$668.60M	+4.3%
Mar 2015	$640.80M	+2.2%
Dec 2014	$627.20M	-2.7%
Sep 2014	$644.30M	-2.3%
Jun 2014	$659.40M	-9.1%
Mar 2014	$725.30M	-14.9%
Dec 2013	$852.50M	-4.4%
Sep 2013	$892.00M	-4.0%
Jun 2013	$929.20M	-0.7%
Mar 2013	$936.00M	+6.6%

Month	Value	Change
Dec 2012	$878.10M	+5.9%
Sep 2012	$829.50M	+4.1%
Jun 2012	$797.00M	+7.7%
Mar 2012	$739.80M	+6.5%
Dec 2011	$694.80M	+7.1%
Sep 2011	$649.00M	+7.8%
Jun 2011	$602.20M	+5.3%
Mar 2011	$571.90M	+3.4%
Dec 2010	$553.30M	+4.8%
Sep 2010	$527.98M	+5.5%
Jun 2010	$500.37M	+8.3%
Mar 2010	$462.11M	+22.4%
Dec 2009	$377.44M	+13.8%
Sep 2009	$331.79M	+6.2%
Jun 2009	$312.34M	+7.3%
Mar 2009	$290.99M	-6.4%
Dec 2008	$310.84M	+3.1%
Sep 2008	$301.55M	+11.4%
Jun 2008	$270.60M	+13.8%
Mar 2008	$237.83M	+14.6%
Dec 2007	$207.56M	+22.4%
Sep 2007	$169.55M	+20.1%
Jun 2007	$141.15M	+17.4%
Mar 2007	$120.23M	+12.0%
Dec 2006	$107.36M	+12.5%
Sep 2006	$95.42M	+5.1%
Jun 2006	$90.75M	+11.2%
Mar 2006	$81.58M	+18.6%
Dec 2005	$68.77M	+22.4%
Sep 2005	$56.21M	+38.2%
Jun 2005	$40.69M	+36.5%
Mar 2005	$29.82M	+40.7%
Dec 2004	$21.18M	+305.5%
Sep 2004	$5.22M	+494.0%
Jun 2004	-$1.33M	+74.8%
Mar 2004	-$5.26M	+39.4%
Dec 2003	-$8.68M	-30.3%
Sep 2003	-$6.66M	+46.5%
Jun 2003	-$12.44M	+27.8%
Mar 2003	-$17.24M	+14.7%
Dec 2002	-$20.22M	+9.3%
Sep 2002	-$22.28M	-4.7%
Jun 2002	-$21.28M	+3.1%
Mar 2002	-$21.95M	-7.7%
Dec 2001	-$20.38M	+5.8%
Sep 2001	-$21.64M	-2.0%
Jun 2001	-$21.23M	+1.1%
Mar 2001	-$21.46M	+3.7%
Dec 2000	-$22.28M	-39.6%
Sep 2000	-$15.96M	-51.4%
Jun 2000	-$10.54M	-96.4%
Mar 2000	-$5.37M	-

FAQ

What is the current TTM EBIT of ISRG?
As of today, ISRG TTM EBIT is $2.95B
What is ISRG TTM EBIT most recent change?
ISRG TTM EBIT was up +4.60% on December 31, 2025
What is 1-year change in ISRG TTM EBIT?
ISRG TTM EBIT is up +25.40% year-over-year
How far is ISRG TTM EBIT from its all-time high?
ISRG TTM EBIT is currently at its all-time high
How does ISRG TTM EBIT rank versus sector peers?
ISRG TTM EBIT is higher than 97.14% of companies in Healthcare sector
When is ISRG next earnings release?
The next earnings release for ISRG is on April 21, 2026

EBIT Formula

EBIT = Revenue − Cost Of Goods Sold − Operating Expenses

Data Sources & References

ISRG Official Website www.intuitive.com
ISRG Profile on Yahoo Finance finance.yahoo.com/quote/ISRG
ISRG Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/isrg